Equity Analysis

Company News

    Remus Pharmaceuticals Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    78788
    INE0O5T01011
    139.278683
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    REMUS
    82.72
    1390.04
    EPS(TTM)
    Face Value()
    Div & Yield %:
    28.52
    10
    0
     
Remus Pharmaceuticals Ltd
Board of Remus Pharmaceuticals recommends interim dividend
Nov 09,2024
Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 9 November 2024, inter alia, have recommended the interim dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.